ArticlePharmaceutics2021

Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein.

Javad Garousi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.